Reference SummaryDeStefano Shields CE, Cancer Discov 2021 Feb 25;():
Title |
Bacterial-Driven Inflammation and Mutant BRAF Expression Combine to Promote Murine Colon Tumorigenesis That Is Sensitive to Immune Checkpoint Therapy. |
Authors |
DeStefano Shields CE; White JR; Chung L; Wenzel A; Hicks JL; Tam AJ; Chan JL; Dejea CM; Fan H; Michel J; Maiuri AR; Sriramkumar S; Podicheti R; Rusch DB; Wang H; De Marzo AM; Besharati S; Anders RA; Baylin SB; O'Hagan HM; Housseau F; Sears CL |
Journal |
Cancer Discov |
Volume |
|
Issue |
|
Year |
2021 |
Pages |
|
Abstract |
Colorectal cancer is multifaceted, with subtypes defined by genetic, histologic, and immunologic features that are potentially influenced by inflammation, mutagens, and/or microbiota. Colorectal cancers with activating mutations in BRAF are associated with distinct clinical characteristics, although the pathogenesis is not well understood. The Wnt-driven multiple intestinal neoplasia (Min(ApcDelta716/+)) enterotoxigenic Bacteroides fragilis (ETBF) murine model is characterized by IL17-dependent, distal colon adenomas. Herein, we report that the addition of the BRAF (V600E) mutation to this model results in the emergence of a distinct locus of midcolon tumors. In ETBF-colonized BRAF (V600E) Lgr5 (Cre)Min (BLM) mice, tumors have similarities to human BRAF (V600E) tumors, including histology, CpG island DNA hypermethylation, and immune signatures. In comparison to Min ETBF tumors, BLM ETBF tumors are infiltrated by CD8(+) T cells, express IFNgamma signatures, and are sensitive to anti-PD-L1 treatment. These results provide direct evidence for critical roles of host genetic and microbiota interactions in colorectal cancer pathogenesis and sensitivity to immunotherapy. SIGNIFICANCE: Colorectal cancers with BRAF mutations have distinct characteristics. We present evidence of specific colorectal cancer gene-microbial interactions in which colonization with toxigenic bacteria drives tumorigenesis in BRAF (V600E) Lgr5 (Cre)Min mice, wherein tumors phenocopy aspects of human BRAF-mutated tumors and have a distinct IFNgamma-dominant immune microenvironment uniquely responsive to immune checkpoint blockade. |
Links |
J:307164 – MGI References 33632774 – National Library of Medicine/PubMed |
Strain | Model Name | Treatment Agent(s) | Organ Affected | Frequency | Model Details |
---|---|---|---|---|---|
C57BL/6-Apctm1Mmt/+ | Intestine - Large Intestine - Colon - Distal tumor |
|
Intestine - Large Intestine - Colon - Distal |
72.97 - 100 |
|
C57BL/6-Apctm1Mmt/+ Braftm1Mmcm/+Lgr5tm1(cre/ERT2)Cle/+ | Intestine - Large Intestine - Colon - Distal tumor |
|
Intestine - Large Intestine - Colon - Distal |
82.93 - 100 |
|
C57BL/6-Apctm1Mmt/+ Krastm4Tyj/+ Lgr5tm1(cre/ERT2)Cle/+ | Intestine - Large Intestine - Colon - Distal tumor |
|
Intestine - Large Intestine - Colon - Distal |
55.56 - 100 |
|
C57BL/6-Apctm1Mmt/+ | Intestine - Large Intestine - Colon - Distal tumor | Intestine - Large Intestine - Colon - Distal |
very low |
||
C57BL/6-Apctm1Mmt/+ Braftm1Mmcm/+Lgr5tm1(cre/ERT2)Cle/+ | Intestine - Large Intestine - Colon - Distal tumor | Intestine - Large Intestine - Colon - Distal |
very low |
||
C57BL/6-Apctm1Mmt/+ | Intestine - Large Intestine - Colon - Distal tumor |
|
Intestine - Large Intestine - Colon - Distal |
100 |
|
C57BL/6-Apctm1Mmt/+ Braftm1Mmcm/+Lgr5tm1(cre/ERT2)Cle/+ | Intestine - Large Intestine - Colon - Distal tumor |
|
Intestine - Large Intestine - Colon - Distal |
100 |
|
C57BL/6-Apctm1Mmt/+ | Intestine - Large Intestine - Colon - Proximal tumor |
|
Intestine - Large Intestine - Colon - Proximal |
0 - 100 |
|
C57BL/6-Apctm1Mmt/+ Braftm1Mmcm/+Lgr5tm1(cre/ERT2)Cle/+ | Intestine - Large Intestine - Colon - Proximal tumor |
|
Intestine - Large Intestine - Colon - Proximal |
9.76 - 97.56 |
|
C57BL/6-Apctm1Mmt/+ Krastm4Tyj/+ Lgr5tm1(cre/ERT2)Cle/+ | Intestine - Large Intestine - Colon - Proximal tumor |
|
Intestine - Large Intestine - Colon - Proximal |
11.11 - 33.33 |
|
C57BL/6-Apctm1Mmt/+ | Intestine - Large Intestine - Colon - Proximal tumor |
|
Intestine - Large Intestine - Colon - Proximal |
100 |
|
C57BL/6-Apctm1Mmt/+ Braftm1Mmcm/+Lgr5tm1(cre/ERT2)Cle/+ | Intestine - Large Intestine - Colon - Proximal tumor |
|
Intestine - Large Intestine - Colon - Proximal |
71.43 |
|
C57BL/6-Apctm1Mmt/+ | Intestine - Large Intestine - Colon adenoma |
|
Intestine - Large Intestine - Colon |
observed |
|
C57BL/6-Apctm1Mmt/+ Braftm1Mmcm/+Lgr5tm1(cre/ERT2)Cle/+ | Intestine - Large Intestine - Colon adenoma |
|
Intestine - Large Intestine - Colon |
observed |
|
C57BL/6-Apctm1Mmt/+ | Intestine - Large Intestine - Colon adenoma - microadenoma |
|
Intestine - Large Intestine - Colon |
58.33 |
|
C57BL/6-Apctm1Mmt/+ Braftm1Mmcm/+Lgr5tm1(cre/ERT2)Cle/+ | Intestine - Large Intestine - Colon adenoma - microadenoma |
|
Intestine - Large Intestine - Colon |
86.67 |
|
C57BL/6-Apctm1Mmt/+ | Intestine - Large Intestine - Colon adenoma - microadenoma | Intestine - Large Intestine - Colon |
very low |
||
C57BL/6-Apctm1Mmt/+ Braftm1Mmcm/+Lgr5tm1(cre/ERT2)Cle/+ | Intestine - Large Intestine - Colon adenoma - microadenoma | Intestine - Large Intestine - Colon |
very low |
||
C57BL/6-Apctm1Mmt/+ | Intestine - Large Intestine - Colon adenoma - tubular |
|
Intestine - Large Intestine - Colon |
observed |
|
C57BL/6-Apctm1Mmt/+ Braftm1Mmcm/+Lgr5tm1(cre/ERT2)Cle/+ | Intestine - Large Intestine - Colon adenoma - tubular |
|
Intestine - Large Intestine - Colon |
observed |
|
C57BL/6-Apctm1Mmt/+ Braftm1Mmcm/+Lgr5tm1(cre/ERT2)Cle/+ | Intestine - Large Intestine - Colon adenoma - villous |
|
Intestine - Large Intestine - Colon |
observed |
|
C57BL/6-Apctm1Mmt/+ Braftm1Mmcm/+Lgr5tm1(cre/ERT2)Cle/+ | Intestine - Large Intestine - Colon dysplasia |
|
Intestine - Large Intestine - Colon |
observed |
|
C57BL/6J | Intestine - Large Intestine - Colon tumor |
|
Intestine - Large Intestine - Colon |
0 |
|
C57BL/6-Braftm1Mmcm/+Lgr5tm1(cre/ERT2)Cle/+ | Intestine - Large Intestine - Colon tumor |
|
Intestine - Large Intestine - Colon |
0 |
|
C57BL/6-Apctm1Mmt/+ | Intestine - Large Intestine - Colon tumor |
|
Intestine - Large Intestine - Colon |
observed - 100 |
|
C57BL/6-Apctm1Mmt/+ Braftm1Mmcm/+Lgr5tm1(cre/ERT2)Cle/+ | Intestine - Large Intestine - Colon tumor |
|
Intestine - Large Intestine - Colon |
observed - 100 |
|
C57BL/6-Apctm1Mmt/+ Krastm4Tyj/+ Lgr5tm1(cre/ERT2)Cle/+ | Intestine - Large Intestine - Colon tumor |
|
Intestine - Large Intestine - Colon |
77.78 |
|
C57BL/6-Apctm1Mmt/+ | Intestine - Large Intestine - Colon tumor | Intestine - Large Intestine - Colon |
very low |
||
C57BL/6-Apctm1Mmt/+ Braftm1Mmcm/+Lgr5tm1(cre/ERT2)Cle/+ | Intestine - Large Intestine - Colon tumor | Intestine - Large Intestine - Colon |
very low |
||
C57BL/6-Apctm1Mmt/+ | Intestine - Large Intestine - Colon tumor |
|
Intestine - Large Intestine - Colon |
100 |
|
C57BL/6-Apctm1Mmt/+ Braftm1Mmcm/+Lgr5tm1(cre/ERT2)Cle/+ | Intestine - Large Intestine - Colon tumor |
|
Intestine - Large Intestine - Colon |
100 |
|
C57BL/6-Apctm1Mmt/+ Braftm1Mmcm/+Lgr5tm1(cre/ERT2)Cle/+ | Intestine - Large Intestine - Colon tumor - serrated |
|
Intestine - Large Intestine - Colon |
observed |
|
C57BL/6-Apctm1Mmt/+ Braftm1Mmcm/+Lgr5tm1(cre/ERT2)Cle/+ | Intestine - Large Intestine - Colon tumor - sessile |
|
Intestine - Large Intestine - Colon |
observed |